Food & Food Contact Materials
CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
C&K Testing
Carbon Neutrality
Search

China SAMR Collects Public Comments on the Procedures for Priority Review and Approval of Registration of Foods For Special Medical Purpose (Draft)

from CIRS by

China,Priority,Review,Approval,Registration,FSMP

In order to standardize the procedure for the priority review and approval of registration of food for special medical purpose (FSMP), in accordance with the Administrative Measures for the Registration of Foods for Special Medical Purpose, the State Administration for Market Regulation (SAMR) has drafted the Procedures for Priority Review and Approval of Registration of Foods For Special Medical Purpose for public feedback. Comments are welcomed before May 30, 2024.

The public can provide feedback via the following channels:

  • Visit the official website of SAMR (http://www.samr.gov.cn), and submit opinions under the “Interaction” column on the homepage;
  • Send opinions and suggestions via email to tsspsypzcc@samr.gov.cn, with the subject of Opinions on Procedures for Priority Review and Approval of Registration of Foods for Special Medical Purpose; and
  • Send opinions and suggestions via mail to the Special Food Division of the State Administration for Market Regulation at No. 9 Madian East Road, Haidian District, Beijing, 100088, with the envelope marked Opinions on Procedures for Priority Review and Approval of Registration of Foods for Special Medical Purpose.

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Further Information

SAMR Announcement

  

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)
Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)